https://www.selleckchem.com/pr....oducts/chaetocin.htm
At a median follow-up of 20 months, local recurrence was similar irrespective of fiducial placement (adjusted hazard ratio [aHR] 0.6, 95% CI 0.3-1.3, = .59). Furthermore, no difference in overall survival was noted between the 2 groups (aHR 0.8, 95% CI 0.3-1.9, = .65). In patients who eventually underwent surgery post-SBRT, no difference in surgical margins ( = .4 or lymphovascular invasion ( = .76) was noted between the 2 groups. No patient developed acute pancreatitis after fiducial placement. Our data suggest that the use of fidu
Like
Comment
Share
